Retour
Prix Ucb SA (UCBJY)
Graphique du cours de l'action UCBJY
UCBJY Gagner
Ucb SA
$153.7
2.33%
$3.5
À la fermeture : Jan 16, 16:00:00 GMT-5
$153.7
0%
$0
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$150.19
Prix d'ouverture
$154.91
Plage de la journée
$152.49 - $154.91
Plage de 52 semaines
$71.15 - $154.77
Volume
5.1K
Volume moyen
27.4K
BPA (TTM)
4.02
Rendement en dividend
--
Capitalisation boursière
$58.4B
Qu’est-ce que UCBJY ?
UCB SA engages in the research and development of biopharmaceuticals products. The company is headquartered in Anderlecht, Bruxelles-Capitale and currently employs 9,378 full-time employees. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved